EGM
PLRX icon

Engineers Gate Manager’s Pliant Therapeutics PLRX Stock Holding History

Engineers Gate Manager’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-30,544
Closed -$37.3K – 2477
2025
Q4 		$37.3K Buy
30,544
+7,056
+30% +$10.6K ﹤0.01% 1998
2025
Q3 		$34.8K Sell
23,488
-7,935
-25% -$12.1K ﹤0.01% 2083
2025
Q2 		$36.5K Buy
31,423
+18,300
+139% +$25.9K ﹤0.01% 2072
2025
Q1 		$17.7K Buy
+13,123
New +$79.7K ﹤0.01% 2084
2024
Q4 		– Sell
-12,229
Closed -$137K – 2501
2024
Q3 		$137K Buy
+12,229
New +$153K ﹤0.01% 1876
2023
Q2 		– Sell
-14,789
Closed -$393K – 1953
2023
Q1 		$393K Buy
+14,789
New +$421K 0.02% 1102

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

Engineers Gate Manager's PLRX Position: Q1 2026 in Review

Engineers Gate Manager sold out of Pliant Therapeutics (PLRX) in Q1 2026, closing a stake of 30,544 shares — an estimated $37.3K sold.

Engineers Gate Manager first reported a position in PLRX in Q1 2023 and held it in 6 quarters. The position peaked at $393K in Q1 2023. 91 funds tracked by Wall St. Rank hold PLRX as of Q1 2026.

  • Engineers Gate Manager reported no remaining Pliant Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Engineers Gate Manager sold 30,544 Pliant Therapeutics shares in Q1 2026, an estimated $37.3K.
  • Engineers Gate Manager first reported a position in Pliant Therapeutics in Q1 2023 and held it in 6 quarters.
  • Engineers Gate Manager's Pliant Therapeutics position peaked at $393K in Q1 2023.
  • 91 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.